Cadence OTC Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 15

Employees
  • Latest Deal Type

  • Series C

  • Latest Deal Amount

  • $14.1M

  • Investors

  • 9

Cadence OTC General Information

Description

Manufacturer of birth control pills intended to provide assistance in the process of unwanted pregnancy. The company's product portfolio includes oral contraceptive pills under over-the-counter status without any prescription, enabling users to knock down the obstacles between women and the reproductive health options.

Contact Information

Website
www.cadenceotc.com
Formerly Known As
Pelagius
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • 1440 Broadway
  • Suite 750
  • Oakland, CA 94612
  • United States
+1 (713) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cadence OTC Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 01-Sep-2020 $14.1M 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series B) 01-Jan-2019 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 22-Feb-2018 $4.47M $5.22M 000.00 Completed Generating Revenue
1. Angel (individual) 21-Jan-2016 $750K $750K Completed Startup
To view Cadence OTC’s complete valuation and funding history, request access »

Cadence OTC Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C-1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series C-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.00
Series B-1 2,653,928 $0.000100 $0.3 $3.77 $3.77 1x $3.77 14.48%
Series A 5,722,584 $0.000100 $0.12 $1.47 $1.47 1x $1.47 31.23%
To view Cadence OTC’s complete cap table history, request access »

Cadence OTC Executive Team (4)

Name Title Board Seat Contact Info
Robert Hosang MD Co-Founder, Co-Chief Executive Officer, Chief Medical Officer & Board Member
Samantha Miller Co-Founder, Board Observer & Co-Chief Executive Officer
Katherine Pence Director, Finance & Administration
David Potts Ph.D Board Member & Co-Founder
To view Cadence OTC’s complete executive team members history, request access »

Cadence OTC Board Members (9)

Name Representing Role Since
Abigail Disney Self Board Member 000 0000
Connie Evans Self Board Member 000 0000
David Potts Ph.D Cadence OTC Board Member & Co-Founder 000 0000
Gregory Martin Self Board Observer 000 0000
Nathalie Nino Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Cadence OTC Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cadence OTC Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Elizabeth Banks Angel (individual) Minority 000 0000 000000 0
Stardust Equity Family Office Minority 000 0000 000000 0
Steyn Group Family Office Minority 000 0000 000000 0
The Global Fund for Women Impact Investing Minority 000 0000 000000 0
The Sant Foundation Corporation Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial